Connect with us

Hi, what are you looking for?

Monday, Mar 4, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

Canada grants terminal patients access to psilocybin therapy

Four patients will be the first Canadians to legally access the psychedelic in almost 50 years

Canada grants terminal patients access to psilocybin therapy

Four Canadians with terminal cancer have been granted the right to access psilocybin therapy by Health Minister Patty Hajdu.

On Tuesday, the quartet became the first people to be publicly granted the right to access the psychedelic since it was criminalized in 1974, according to the non-profit TheraPsil.

The patients will be able to legally use the drug through what is known as compassionate access, which allows for exemptions under the Canadian Drugs and Substances Act.

TheraPsil is a Victoria, B.C.-based coalition of healthcare workers, patients and advocates who have been working since 2019 to help people with terminal illnesses access psilocybin through compassionate access. The psychedelic can be used to treat people’s end-of-life anxiety, TheraPsil said.

The decision came 100 days after patients applied for the exemption.

“Although it has taken a long time we are impressed with [the government’s] willingness to listen to patients who have not been heard and to shift focus and policy to accommodate their interests and protect their needs,” TheraPsil founder Bruce Tobin said in a statement.

“We also thank the brave Canadian patients who have been public in their fight for psilocybin access, along with the honourable Canadian MPs who have demonstrated courage standing up for patient rights,” he said.

Laurie Brooks is one of the patients approved for compassionate access.

“The acknowledgement of the pain and anxiety that I have been suffering with means a lot to me, and I am feeling quite emotional today as a result,” the B.C. local said in the statement. “I hope this is just the beginning and that soon all Canadians will be able to access psilocybin, for therapeutic use, to help with the pain they are experiencing, without having to petition the government for months to gain permission.” 

Exemptions for compassionate access aren’t just granted for palliative patients. Just last year, the British Columbia Centre on Substance Use published a report calling on the government to grant compassionate access to heroin for people with opioid dependancy.

Following Tuesday’s news, the number of Canadians applying for compassionate access is likely to rise, predicted TheraPsil.

Thomas Hartle is the second patient named who won the right to access psilocybin. The other two patients remained anonymous.

“I would like to personally thank the Hon. Minister Hajdu and the team at the Office of Controlled Substances for the approval of my section 56 exemption,” Hartle said. “This is a positive result that is possible when good people show genuine compassion. I’m so grateful that I can move forward with the next step of healing.”

The Canadian Drugs and Substances Act prohibits the use of psychedelics but a movement to legalize all plants and fungi with traditional use has been gaining momentum. Green Party MP Paul Manley will present a petition calling for legalization to parliament later this year. The petition has been signed 8,728 times.

Read more: First official call to decriminalize psychedelics in Canada to he heard later this year

Top image by Ilkka S. Itäheima via Wikimedia Commons


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month

Health & Wellness

Partnership signals a milestone agreement for innovative treatment solutions 


The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary


The funding was led by the non-profit Helena, a diverse organization that aims to solve global problems